Drugs for Life: How Pharmaceutical Companies Define Our Health Audiobook By Joseph Dumit cover art

Drugs for Life: How Pharmaceutical Companies Define Our Health

Experimental Futures

Preview

Try for $0.00
Prime logo Prime members: New to Audible?
Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.

Drugs for Life: How Pharmaceutical Companies Define Our Health

By: Joseph Dumit
Narrated by: John Brancy
Try for $0.00

$14.95/month after 30 days. Cancel anytime.

Buy for $19.95

Buy for $19.95

Confirm purchase
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
Cancel

About this listen

Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one-fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but also came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market and profits that they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs.

The book is published by Duke University Press.

©2012 Duke University Press (P)2013 Redwood Audiobooks
Anthropology Business & Careers Physical Illness & Disease Social Sciences Health care Pain management Medical Insurance
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Drugs for Life: How Pharmaceutical Companies Define Our Health

Average customer ratings
Overall
  • 4.5 out of 5 stars
  • 5 Stars
    13
  • 4 Stars
    4
  • 3 Stars
    1
  • 2 Stars
    2
  • 1 Stars
    0
Performance
  • 4.5 out of 5 stars
  • 5 Stars
    7
  • 4 Stars
    6
  • 3 Stars
    1
  • 2 Stars
    1
  • 1 Stars
    0
Story
  • 4 out of 5 stars
  • 5 Stars
    8
  • 4 Stars
    3
  • 3 Stars
    1
  • 2 Stars
    1
  • 1 Stars
    1

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

An even handed critique of industry

Considered and nuanced. Argument is compelling and avoids paranoid conspiracy. Sometimes books about the pharma industry lapse into Q-anonesque thinking. Dumit maps how a larger social systems funnel us to problematic conceptions of health.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

  • Overall
    2 out of 5 stars
  • Performance
    4 out of 5 stars
  • Story
    3 out of 5 stars

Snoozefest

I work in the industry, so I am interested in books written about pharmaceuticals. This book is mind numbing, however. The author brings up many interesting points, but it just so boring and flat that the phone book would have held my interest more. If I hadn't just returned the previous book, I would have asked for my credit back for this one. Skip it.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!

1 person found this helpful